Literature DB >> 19730930

Which placement of the tension-free vaginal tape is more important for urinary continence: midurethral position or bladder neck? Consideration from a case report.

Fengmei Wang1, Yanfeng Song, Huijuan Huang.   

Abstract

The tension-free vaginal tape (TVT) is a well-established surgical procedure for the treatment of female urinary stress incontinence. Midurethral position was thought not to be necessary to achieve continence. But in our study, a patient with stress urinary incontinence was treated with a TVT suburethral sling. The symptoms of stress urinary incontinence still exist after the TVT procedure. With physical treatment and anti-inflammatory treatment, no relief was found. At the 50-day follow-up, the symptoms of stress incontinence worsened. Transperineal three-dimensional ultrasound revealed that the sling migrated from the midurethra to the bladder neck. With adjustment of the sling, the symptom of stress incontinence was improved and no complication was observed at the 6- and 12-month follow-up. Sling migration should be considered in a patient who presents with recurrent stress incontinence at the earlier postoperative period. We think that the midurethral position is necessary to achieve continence.

Entities:  

Mesh:

Year:  2009        PMID: 19730930     DOI: 10.1007/s00192-009-0859-0

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  5 in total

1.  Rare complications of tension-free vaginal tape procedure: late intraurethral displacement and early misplacement of tape.

Authors:  Maarten-Jan Pit
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

Review 2.  An integral theory and its method for the diagnosis and management of female urinary incontinence.

Authors:  P E Petros; U I Ulmsten
Journal:  Scand J Urol Nephrol Suppl       Date:  1993

3.  Use of three-dimensional ultrasound scan to assess the clinical importance of midurethral placement of the tension-free vaginal tape (TVT) for treatment of incontinence.

Authors:  Christopher C M Ng; L C Lee; William H C Han
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-11-06

Review 4.  [Per- and postoperative complications of TVT (tension-free vaginal tape)].

Authors:  Fabrice Sergent; Anthony Sebban; Eric Verspyck; Loïc Sentilhes; Jean-Paul Lemoine; Loïc Marpeau
Journal:  Prog Urol       Date:  2003-09       Impact factor: 0.915

5.  Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis.

Authors:  J O DeLancey
Journal:  Am J Obstet Gynecol       Date:  1994-06       Impact factor: 8.661

  5 in total
  5 in total

1.  Anatomical variation of bony pelvis from the viewpoint of transobturator sling placement for stress urinary incontinence.

Authors:  Michał Bogusiewicz; Katarzyna Rosińska-Bogusiewicz; Andrzej Drop; Tomasz Rechberger
Journal:  Int Urogynecol J       Date:  2011-04-12       Impact factor: 2.894

2.  Ultrasound imaging in urogynecology - state of the art 2016.

Authors:  Michał Bogusiewicz
Journal:  Prz Menopauzalny       Date:  2016-11-15

3.  Both the middle and distal sections of the urethra may be regarded as optimal targets for 'outside-in' transobturator tape placement.

Authors:  Michał Bogusiewicz; Marta Monist; Krzysztof Gałczyński; Magdalena Woźniak; Andrzej P Wieczorek; Tomasz Rechberger
Journal:  World J Urol       Date:  2014-02-17       Impact factor: 4.226

4.  Comparison of Effectiveness between Tension-Free Vaginal Tape (TVT) and Trans-Obturator Tape (TOT) in Patients with Stress Urinary Incontinence and Intrinsic Sphincter Deficiency.

Authors:  Hyeong Gon Kim; Hyoung Keun Park; Sung Hyun Paick; Woo Suk Choi
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

5.  Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery.

Authors:  Pawel Miotla; Konrad Futyma; Rufus Cartwright; Michal Bogusiewicz; Katarzyna Skorupska; Ewa Markut-Miotla; Tomasz Rechberger
Journal:  Int Urogynecol J       Date:  2015-09-12       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.